Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple blood test could predict success of cancer immunotherapy

NCT ID NCT07018310

Summary

This study aims to develop a simple blood test to check if a patient's immune system is ready to fight blood cancer before starting immunotherapy. Researchers will analyze blood samples from 166 adults with blood cancers to measure how well their immune cells respond to stimulation. The goal is to create a test that could help doctors predict which patients will benefit most from immunotherapy treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Assisitance Publique Hôpitaux de Marseille

    Marseille, 13005, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.